WORCESTER, Mass., May 13, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it hosted a satellite symposium at The 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension being held May 13 – 16, 2010 in Prague, Czech Republic (www.comtecmed.com/codhy/2010).
